Works matching DE "PROTEIN kinase inhibitors"
Results: 2841
Management of Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 10, p. 841
- By:
- Publication type:
- Article
What Next? Choosing Second-Line Therapy in Progressive Renal Cell Carcinoma.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 794, doi. 10.46883/onc.2014.2809.0794
- By:
- Publication type:
- Article
An Update on Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 9, p. 749
- By:
- Publication type:
- Article
Cardiovascular Toxicity of Newer Chemotherapeutic Agents: The Heart of the Matter.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 6, p. 493
- By:
- Publication type:
- Article
Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.
- Published in:
- Nature Structural & Molecular Biology, 2014, v. 21, n. 8, p. 696, doi. 10.1038/nsmb.2846
- By:
- Publication type:
- Article
NCCN adds lenvatinib/pembrolizumab to Category 1 recommendation.
- Published in:
- Urology Times, 2021, v. 49, n. 5, p. 34
- By:
- Publication type:
- Article
Onvansertib is active in patients with abiraterone-resistant prostate cancer: More than one-third of patients undergoing treatment had disease control at 12 weeks.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 10
- By:
- Publication type:
- Article
First-line pembrolizumab/axitinib sustains survival benefit in kidney cancer.
- Published in:
- Urology Times, 2020, v. 48, n. 12, p. 34
- By:
- Publication type:
- Article
UPDATES ON DRUGS, DEVICES, AND TESTS.
- Published in:
- Urology Times, 2020, v. 48, n. 11, p. 8
- By:
- Publication type:
- Article
RCC combo therapy significantly improves PFS.
- Published in:
- Urology Times, 2019, v. 47, n. 1, p. 9
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Trilaciclib for the reduction of chemotherapy-induced myelosuppression in the management of extensive-stage small cell lung cancer: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 2, p. 64, doi. 10.1007/s40267-021-00889-0
- By:
- Publication type:
- Article
Personalized Care in the Prevention of Treatment-Related Cardiac Dysfunction in Female Cancer Survivors.
- Published in:
- Journal of Women's Health (15409996), 2019, v. 28, n. 10, p. 1384, doi. 10.1089/jwh.2018.6979
- By:
- Publication type:
- Article
A comparison of molecular representations for lipophilicity quantitative structure–property relationships with results from the SAMPL6 logP Prediction Challenge.
- Published in:
- Journal of Computer-Aided Molecular Design, 2020, v. 34, n. 5, p. 523, doi. 10.1007/s10822-020-00279-0
- By:
- Publication type:
- Article
Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.
- Published in:
- Journal of Computer-Aided Molecular Design, 2019, v. 33, n. 8, p. 745, doi. 10.1007/s10822-019-00221-z
- By:
- Publication type:
- Article
A combined Fisher and Laplacian score for feature selection in QSAR based drug design using compounds with known and unknown activities.
- Published in:
- Journal of Computer-Aided Molecular Design, 2018, v. 32, n. 2, p. 375, doi. 10.1007/s10822-017-0094-6
- By:
- Publication type:
- Article
Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: The more, the better?
- Published in:
- Cancer & Metastasis Reviews, 2023, v. 42, n. 2, p. 481, doi. 10.1007/s10555-023-10097-z
- By:
- Publication type:
- Article
Primary lesion radiotherapy during first-line icotinib treatment in EGFR-mutated NSCLC patients with multiple metastases and no brain metastases: a single-center retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Recall-Strahlendermatitis durch Sorafenib : Eine Fallstudie und Literaturübersicht.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Emerging treatments for corneal endothelium decompensation — a systematic review.
- Published in:
- Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 2, p. 381, doi. 10.1007/s00417-023-06129-7
- By:
- Publication type:
- Article
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 9, p. 1373, doi. 10.1007/s00228-024-03713-6
- By:
- Publication type:
- Article
The effect of concomitant use of proton pump inhibitors with CDK 4/6 inhibitors on survival in metastatic breast cancer.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 2, p. 243, doi. 10.1007/s00228-022-03435-7
- By:
- Publication type:
- Article
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1239, doi. 10.1007/s00228-022-03331-0
- By:
- Publication type:
- Article
Influences of ABC transporter and CYP3A4/5 genetic polymorphisms on the pharmacokinetics of lenvatinib in Chinese healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 8, p. 1125, doi. 10.1007/s00228-020-02879-z
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 6, p. 717, doi. 10.1007/s00228-017-2217-3
- By:
- Publication type:
- Article
Sunitinib treatment in a patient with metastatic renal cell carcinoma and bariatric surgery.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 10, p. 1175, doi. 10.1007/s00228-015-1920-1
- By:
- Publication type:
- Article
Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 5, p. 531, doi. 10.1007/s00228-014-1654-5
- By:
- Publication type:
- Article
The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand–foot syndrome.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2065, doi. 10.1007/s00228-013-1579-4
- By:
- Publication type:
- Article
Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer.
- Published in:
- Archives of Gynecology & Obstetrics, 2013, v. 288, n. 1, p. 155, doi. 10.1007/s00404-012-2706-7
- By:
- Publication type:
- Article
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
- Published in:
- Nature, 2013, v. 497, n. 7451, p. 638, doi. 10.1038/nature12205
- By:
- Publication type:
- Article
Severe Hyperglycemia Due to Protein Kinase Inhibitor Therapy in a Patient With Poorly Controlled Diabetes Mellitus.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad172
- By:
- Publication type:
- Article
Xerosis as the toxicity of novel anti-cancer therapies — pathophysiology and management.
- Published in:
- Forum Dermatologicum, 2023, v. 9, n. 2, p. 50, doi. 10.5603/FD.a2023.0004
- By:
- Publication type:
- Article
Prognostic and Predictive Significance of HER2-low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy.
- Published in:
- European Journal of Therapeutics, 2024, v. 30, n. 5, p. 662, doi. 10.58600/eurjther2151
- By:
- Publication type:
- Article
ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways.
- Published in:
- Science Immunology, 2016, v. 1, n. 2, p. 1, doi. 10.1126/sciimmunol.aag2045
- By:
- Publication type:
- Article
Principiile cercetării imunofarmacologice.
- Published in:
- Farmacist.ro, 2020, n. 4, p. 25
- By:
- Publication type:
- Article
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast.
- Published in:
- Oncology & Therapy, 2023, v. 11, n. 4, p. 411, doi. 10.1007/s40487-023-00237-4
- By:
- Publication type:
- Article
Clarithromycin Modulates Neutrophilic Inflammation Induced by Prevotella intermedia in Human Airway Epithelial Cells.
- Published in:
- Antibiotics (2079-6382), 2024, v. 13, n. 9, p. 909, doi. 10.3390/antibiotics13090909
- By:
- Publication type:
- Article
Clinical significance of raf-1 kinase inhibitor protein in oral squamous cell carcinoma and its role in cell metastasis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 23, p. 12194
- By:
- Publication type:
- Article
Study on correlation between PKIB and pAkt expression in breast cancer tissues.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 6, p. 1264
- By:
- Publication type:
- Article
Clinicopathological Features and Outcomes of Gastrointestinal Stromal Tumours in Oman: A multi-centre study.
- Published in:
- Sultan Qaboos University Medical Journal, 2021, v. 21, n. 2, p. e237, doi. 10.18295/squmj.2021.21.02.012
- By:
- Publication type:
- Article
Proper CycE-Cdk2 activity in endocycling tissues requires regulation of the cyclin-dependent kinase inhibitor Dacapo by dE2F1b in Drosophila.
- Published in:
- Genetics, 2021, v. 217, n. 1, p. 1, doi. 10.1093/genetics/iyaa029
- By:
- Publication type:
- Article
The fission yeast S-phase cyclin Cig2 can drive mitosis.
- Published in:
- Genetics, 2021, v. 217, n. 1, p. 1, doi. 10.1093/genetics/iyaa002
- By:
- Publication type:
- Article
Post-translational Regulation of DNA Polymerase h, a Connection to Damage-Induced Cohesion in Saccharomyces cerevisiae.
- Published in:
- Genetics, 2020, v. 216, n. 4, p. 1009, doi. 10.1534/genetics.120.303494
- By:
- Publication type:
- Article
New ferrocenyl guanidines as potent antioxidants, protein kinase inhibitors and cytotoxic agents against human leukemia THP-1 cell line.
- Published in:
- Russian Journal of General Chemistry, 2017, v. 87, n. 11, p. 2684, doi. 10.1134/S1070363217110251
- By:
- Publication type:
- Article
RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/2282916
- By:
- Publication type:
- Article
Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9999268
- By:
- Publication type:
- Article
Antitumor Effect of Lenvatinib Combined with Alisertib in Hepatocellular Carcinoma by Targeting the DNA Damage Pathway.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6613439
- By:
- Publication type:
- Article
PICK1 Deficiency Exacerbates Sepsis-Associated Acute Kidney Injury.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9884297
- By:
- Publication type:
- Article
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/5556306
- By:
- Publication type:
- Article